Literature DB >> 11603921

Decreased expression of insulin-like growth factor-1 and apoptosis of vascular smooth muscle cells in human atherosclerotic plaque.

Y Okura1, M Brink, A A Zahid, A Anwar, P Delafontaine.   

Abstract

Insulin-like growth factor-1 (IGF-1) plays an important role in migration, cell cycle progression and survival of vascular smooth muscle cells (VSMC). We investigated the specific localization of IGF-1 and its receptor (IGF-1R) and their association with apoptosis and the expression of apoptosis-related proteins in early and advanced atherosclerotic lesions. Human atherosclerotic plaques (n=23) from patients undergoing aortic, carotid or femoral arterial surgery were studied. Immunohistochemistry and in situ hybridization revealed significantly higher expression of IGF-1 and IGF-1R in the media than in the intima of early atherosclerotic lesions (P<0.01). Medial VSMC positive for BAX, a proapoptotic protein of the B-cell CLL/lymphoma 2 (BCL2) family, showed colocalization of IGF-1. Apoptosis, as detected by DNA in situ terminal deoxynucleotidyl transferase end labeling (TUNEL), was not present in these early lesions. In advanced atherosclerotic plaques, the expression of IGF-1 and IGF-1R was significantly lower in the intimal regions with macrophage infiltration than in those without macrophage infiltration or than in the media (P<0.01). Furthermore, IGF-1 and IGF-1R immunoreactivity was markedly lower in intimal TUNEL-positive VSMC compared with intimal BAX-positive and medial VSMC (P<0.01). We conclude that IGF-1 and IGF-1R expression are reduced in the deep intima of early atherosclerotic lesions and in areas of advanced plaques with macrophage infiltration. Since IGF-1 is a potent survival factor for VSMC, poor expression of IGF-1 and IGF-1R in intimal regions with macrophage infiltration would likely contribute to triggering VSMC apoptosis potentially leading to plaque weakening, plaque rupture and acute coronary events. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11603921     DOI: 10.1006/jmcc.2001.1441

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  30 in total

1.  Altered expression of type I insulin-like growth factor receptor in Crohn's disease.

Authors:  F El Yafi; R Winkler; P Delvenne; N Boussif; J Belaiche; E Louis
Journal:  Clin Exp Immunol       Date:  2005-03       Impact factor: 4.330

2.  IGF-1 has plaque-stabilizing effects in atherosclerosis by altering vascular smooth muscle cell phenotype.

Authors:  Jan H von der Thüsen; Keren S Borensztajn; Silvia Moimas; Sandra van Heiningen; Peter Teeling; Theo J C van Berkel; Erik A L Biessen
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

3.  The ubiquitin ligase Nedd4 mediates oxidized low-density lipoprotein-induced downregulation of insulin-like growth factor-1 receptor.

Authors:  Yusuke Higashi; Sergiy Sukhanov; Sampath Parthasarathy; Patrice Delafontaine
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-08-22       Impact factor: 4.733

4.  Transgenic overexpression of pregnancy-associated plasma protein-A in murine arterial smooth muscle accelerates atherosclerotic lesion development.

Authors:  Cheryl A Conover; Megan A Mason; Laurie K Bale; Sean C Harrington; Mette Nyegaard; Claus Oxvig; Michael T Overgaard
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-05-14       Impact factor: 4.733

5.  Insulin-like growth factor-1 induces phosphorylation of PI3K-Akt/PKB to potentiate proliferation of smooth muscle cells in human saphenous vein.

Authors:  Guanghong Jia; Amit K Mitra; Deepak M Gangahar; Devendra K Agrawal
Journal:  Exp Mol Pathol       Date:  2010-05-13       Impact factor: 3.362

6.  Smooth muscle cell-specific insulin-like growth factor-1 overexpression in Apoe-/- mice does not alter atherosclerotic plaque burden but increases features of plaque stability.

Authors:  Shaw-Yung Shai; Sergiy Sukhanov; Yusuke Higashi; Charlotte Vaughn; James Kelly; Patrice Delafontaine
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-07-29       Impact factor: 8.311

7.  Insulin and its analogue glargine do not affect viability and proliferation of human coronary artery endothelial and smooth muscle cells.

Authors:  K Staiger; H Staiger; M A Schweitzer; E Metzinger; B Balletshofer; H-U Häring; M Kellerer
Journal:  Diabetologia       Date:  2005-08-03       Impact factor: 10.122

8.  Nuclear degradation of Wilms tumor 1-associating protein and survivin splice variant switching underlie IGF-1-mediated survival.

Authors:  Theodore W Small; J Geoffrey Pickering
Journal:  J Biol Chem       Date:  2009-07-15       Impact factor: 5.157

Review 9.  IGF-1, oxidative stress and atheroprotection.

Authors:  Yusuke Higashi; Sergiy Sukhanov; Asif Anwar; Shaw-Yung Shai; Patrice Delafontaine
Journal:  Trends Endocrinol Metab       Date:  2010-01-12       Impact factor: 12.015

10.  Presence of irregularity in region between -1115 and -784 nt in P1 promoter of insulin-like growth factor-1 gene may indicate beneficial effect on coronary arteries in a group of patients with stable angina: preliminary data.

Authors:  Pawel Burchardt; Witold Nowak; Anna Gozdzicka-Jozefiak; Rafal Link; Tomasz Grotowski; Anna Wisniecka; Tomasz Siminiak
Journal:  Heart Vessels       Date:  2009-07-22       Impact factor: 2.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.